Brent Sabatini reports a stock award at Vir Biotechnology
By AlphaYouPublished Form 4
Sabatini Brent
Reporting filer
Brent Sabatini reports a stock award, not an open-market purchase or sale, in Vir Biotechnology, Inc.. Form 4 filed Nov 16, 2026 lists 1 entry.
- Disclosed
- Nov 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sabatini Brent | 2026-11-15 | A | Grant or award | 50000 | 0 | 111,902 | 1 day | Filed terms
|
Common Stock
- Owner
- Sabatini Brent
- Date
- 2026-11-15
- Code
- A
- Action
- Grant or award
- Quantity
- 50000
- Price
- 0
- Following holdings
- 111,902
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 50000
- id: F2
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 111902
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sabatini Brent: SVP, Chief Accounting Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F2: 25% of the RSUs will vest on November 15, 2027, and the remaining RSUs will vest in three equal annual installments thereafter.
Original sources
Prepared automatically from public filing data. Report a correction.